Diagnostic paracentesis in every admission, treat SBP with antibiotics plus albumin, safe large-volume paracentesis, and recognise HRS-AKI.
At the bedside
- 1
Diagnostic paracentesis
In every cirrhotic admitted with ascites, GI bleed, encephalopathy, AKI or infection: cell count, culture in blood-culture bottles at bedside, albumin (SAAG), total protein. Coagulopathy is not a contraindication.
- 2
Treat SBP
Ceftriaxone 2 g/day or cefotaxime (community); piperacillin-tazobactam or carbapenem (nosocomial/MDR risk) for 5-7 days. Repeat tap at 48 h if not improving (PMN should fall ≥ 25%).
- 3
Albumin in SBP
1.5 g/kg on day 1 and 1 g/kg on day 3 (reduces AKI and death), especially if creatinine > 1 mg/dL, bilirubin > 4 mg/dL or urea high.
- 4
Secondary bacterial peritonitis
Suspect if PMN very high, multiple organisms, total protein > 1 g/dL, glucose < 50 mg/dL, LDH high: CT and surgical review.
- 5
Large-volume paracentesis
For tense ascites: drain; if > 5 L removed give albumin 6-8 g per litre removed (e.g. 8 L = 48-64 g). Safe without routine FFP/platelets.
- 6
AKI in cirrhosis
Stop diuretics, NSAIDs, nephrotoxins; treat infection; albumin 1 g/kg (max 100 g) for 2 days; if HRS-AKI criteria met, terlipressin + albumin (see AKI module).
- 7
Prophylaxis
Long-term norfloxacin/ciprofloxacin after SBP; avoid beta-blocker hypotension in refractory ascites (SBP < 90 mmHg, Na < 130, AKI).
- Dose
- 1.5 g/kg day 1, 1 g/kg day 3
- Worked example
- 70 kg: 105 g (5 × 100 mL of 20%) day 1, 70 g day 3
Watch for pulmonary oedema.
Large-volume paracentesis > 5 L
Human albumin 20%
- Dose
- 6-8 g per litre removed
- Worked example
- 7 L drained: 42-56 g (2-3 × 100 mL of 20%)
Community-acquired SBP
Ceftriaxone
- Dose
- 2 g once daily for 5-7 days
Ascitic fluid interpretation
| Test | Interpretation |
|---|---|
| PMN ≥ 250/mm³ | SBP (treat empirically) |
| SAAG ≥ 1.1 g/dL | Portal hypertension |
| SAAG < 1.1 g/dL | Non-portal (TB, malignancy, pancreatic) |
| Protein > 1 g/dL + glucose < 50 mg/dL + LDH > serum ULN | Secondary peritonitis (Runyon criteria) |
| ADA raised, lymphocytic, SAAG < 1.1 | Consider tuberculous peritonitis |
References
- 1
- 2
- 3
Pathophysiology
Splanchnic vasodilation reduces effective arterial volume, activating RAAS, SNS and vasopressin; sodium and water retention cause ascites and dilutional hyponatraemia, and renal vasoconstriction causes HRS. Bacterial translocation underlies SBP.
Evidence
- Sort 1999: albumin with cefotaxime reduced renal impairment (10% vs 33%) and mortality (10% vs 29%) in SBP [Sort 1999].
- AASLD 2021 and EASL 2018 guidance on ascites, SBP, paracentesis and HRS [Biggins 2021; EASL 2018].
Controversies
- Long-term albumin (ANSWER vs ATTIRE); beta-blockers in refractory ascites.
🇮🇳 India notes
- Tuberculous peritonitis is an important differential in India (ascitic ADA, lymphocytes, SAAG < 1.1).
- High prevalence of ESBL and carbapenem resistance in Indian hospitals means nosocomial SBP often needs a carbapenem; follow local antibiogram (ICMR AMRSN).
References
- 1
- 2
- 3
Test yourself
Module quiz · score 70% to complete the module
Educational reference for trained clinicians. Check doses against your hospital protocol and the patient in front of you.

